IN VERITAS – The BayneLaw Advantage
Home → Articles & News

The Bayne Law Group LLC Articles & News

FDA releases guidance for industry on notifying the agency of permanent discontinuance or interruption in manufacturing under section 506C of the FD&C Act*

The U.S. Food and Drug Administration has issued a guidance, “Notifying FDA of a Permanent Discontinuance or Interruption in Manufacturing Under Section 506C of the FD&C Act.” Due to the COVID-19 pandemic, FDA has been closely monitoring the medical product supply...